Tecan Group AG

Tecan Group AG

TECN · SW · Healthcare / Medical Instruments & Supplies

251.20CHF-4.40 (-1.72%)

Price History

Full chart

Market Stats

Previous Close255.60
Open254.60
Day Range251.20 – 256.20
52-Week Range109.41 – 256.80
Volume43.66K
Market Cap3.11B
P/E (TTM)0.00
Forward P/E25.64
EPS-9.65
Dividend Yield1.23%
Beta1.01
50-Day Avg202.33
200-Day Avg157.68

About

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Monica Manotas
  • Employees3.00K
  • HeadquartersSeestrasse 103, Männedorf, Switzerland, 8708, Switzerland
  • Websitehttps://www.tecan.com

Leadership

  • Ms. Monica ManotasCEO, Interim Head of the Partnering Business division & Member of Management Board · b. 1973
  • Ms. Camila JapurChief Financial Officer · b. 1982
  • Mr. Andreas WilhelmEVP of Legal, Qua. & Regu. Affairs, Gen. Cou., Sec. of the Board of Dir. & Mem. of Mgmt Board · b. 1969
  • Dr. Ulrich KanterExecutive VP, Global Head of Operations & IT and Member of Management Board · b. 1963
  • Mr. Erik Norström B.Sc., M.Sc.Head of Corporate Development, Executive VP & Member of Management Board · b. 1973
  • Ms. Ingrid PurgstallerChief People Officer & Member of the Management Board · b. 1980
  • Ms. Mukta AcharyaEVP, Head of the Life Sciences Business Division & Member of the Management Board · b. 1984
  • Mr. Carsten BoeghEVP, CTO, Head of Research and Development & Member of Management Board · b. 1968
  • Mr. Martin BrandleSenior Vice President of Corporate Communications & IR
  • Mr. Wolfgang DeuringerPresident of Sales International

Financials

Income Statement

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue332.18M311.61M285.98M344.90M405.93M414.40M396.04M391.91M370.55M376.97M391.11M388.29M399.52M440.30M506.23M548.56M593.79M636.82M730.88M946.62M1.14B1.07B934.28M882.48M
Growth (%)--6.19%-8.23%+20.60%+17.69%+2.09%-4.43%-1.04%-5.45%+1.73%+3.75%-0.72%+2.89%+10.21%+14.97%+8.36%+8.25%+7.25%+14.77%+29.52%+20.88%-6.11%-13.04%-5.54%
Cost of Revenue151.43M153.02M146.20M184.97M212.61M201.98M190.75M193.00M184.40M185.24M192.83M198.69M201.88M224.79M266.87M283.81M315.78M354.09M391.02M558.60M738.94M683.92M613.68M602.29M
Gross Profit180.75M158.58M139.77M159.93M193.32M212.42M205.29M198.91M186.15M191.73M198.28M189.60M197.63M215.50M239.36M264.75M278.02M282.73M339.86M388.02M405.32M390.47M320.60M280.19M
Gross Margin54.41%50.89%48.88%46.37%47.62%51.26%51.84%50.75%50.24%50.86%50.70%48.83%49.47%48.94%47.28%48.26%46.82%44.40%46.50%40.99%35.42%36.34%34.32%31.75%
Operating Expense136.04M136.41M123.02M135.11M142.46M152.12M174.10M139.32M130.18M140.46M145.97M135.14M139.99M148.57M170.70M182.99M190.61M193.81M216.86M246.89M259.37M254.50M245.03M254.95M
Operating Income44.70M22.17M16.75M24.83M50.85M60.30M31.19M59.59M55.97M51.27M52.31M54.46M57.64M66.93M68.66M81.76M87.41M88.92M123.00M141.13M145.95M135.97M75.57M25.24M
Operating Margin13.46%7.12%5.86%7.20%12.53%14.55%7.88%15.20%15.10%13.60%13.37%14.03%14.43%15.20%13.56%14.90%14.72%13.96%16.83%14.91%12.76%12.66%8.09%2.86%
EBITDA59.02M42.83M29.40M33.25M64.22M75.36M74.09M70.22M59.06M62.76M63.08M61.01M64.41M74.14M86.67M92.29M105.64M117.70M154.99M201.22M210.85M205.57M147.80M86.23M
EBITDA Margin17.77%13.74%10.28%9.64%15.82%18.18%18.71%17.92%15.94%16.65%16.13%15.71%16.12%16.84%17.12%16.82%17.79%18.48%21.21%21.26%18.43%19.13%15.82%9.77%
Net Income32.97M14.08M12.72M13.95M40.64M52.38M25.62M49.34M16.20M47.56M42.16M45.67M40.22M57.15M54.54M66.55M70.70M73.17M103.69M121.66M121.13M132.07M67.66M-110.65M
Net Income Margin9.93%4.52%4.45%4.05%10.01%12.64%6.47%12.59%4.37%12.62%10.78%11.76%10.07%12.98%10.77%12.13%11.91%11.49%14.19%12.85%10.59%12.29%7.24%-12.54%
R&D44.57M51.69M37.10M40.76M39.03M41.07M41.87M39.89M37.37M47.00M51.48M59.79M52.98M59.26M55.05M62.32M63.66M48.91M48.64M59.82M60.97M70.01M68.39M68.58M
R&D as % of Total Revenue13.42%16.59%12.97%11.82%9.61%9.91%10.57%10.18%10.09%12.47%13.16%15.40%13.26%13.46%10.87%11.36%10.72%7.68%6.65%6.32%5.33%6.52%7.32%7.77%
Interest Expense383.00K654.00K412.00K2.03M1.64M1.30M1.50M2.26M987.00K130.00K84.00K521.00K455.00K94.00K345.00K471.00K477.00K1.12M1.32M4.25M1.48M1.33M2.71M3.32M
Interest Expense % of Total Revenue0.12%0.21%0.14%0.59%0.40%0.31%0.38%0.58%0.27%0.03%0.02%0.13%0.11%0.02%0.07%0.09%0.08%0.18%0.18%0.45%0.13%0.12%0.29%0.38%

Balance Sheet

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets228.81M224.25M191.31M338.01M365.60M373.98M325.86M348.62M338.50M389.94M421.30M466.65M552.26M641.48M736.16M803.96M857.67M939.77M1.13B2.04B2.16B2.07B2.12B1.70B
Total Liabilities68.58M113.63M97.05M194.68M181.76M169.34M166.68M145.69M110.46M120.63M118.46M130.45M191.06M200.81M249.08M253.84M245.26M280.71M380.48M800.26M776.40M725.06M686.15M546.60M
Total Equity160.22M110.62M94.26M143.33M183.84M204.64M159.19M202.93M228.04M269.31M302.84M336.20M361.20M440.67M487.08M550.12M612.41M659.07M733.65M1.22B1.36B1.35B1.44B1.15B
Cash58.90M67.62M40.16M42.65M85.14M102.85M84.65M91.81M118.04M165.09M144.53M150.38M128.72M208.43M246.74M309.41M296.85M266.27M148.44M121.01M111.44M132.97M154.19M176.37M
Total Debt10.51M41.57M9.49M75.73M55.80M52.93M51.33M41.20M7.42M4.39M3.19M6.91M6.01M9.64M12.04M17.20M7.23M47.88M38.73M313.66M307.68M316.09M321.35M218.32M
Net Debt-48.39M-26.06M-30.67M33.09M-29.35M-49.92M-33.32M-50.61M-110.62M-160.70M-141.34M-143.47M-122.70M-198.79M-234.71M-292.21M-289.62M-218.39M-109.72M192.65M196.24M183.13M167.15M41.95M

Cash Flow

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.00M44.70M29.29M13.45M66.09M58.62M58.93M66.15M62.52M45.12M2.40M27.91M48.19M99.13M118.80M99.43M92.70M98.80M208.34M169.85M128.28M160.57M148.54M137.98M
Investing Cash Flow-19.35M-5.59M-9.83M-64.85M-5.25M-7.35M-5.67M-40.64M-4.46M12.45M-13.35M-19.73M-54.33M-33.51M-54.29M-22.41M-78.44M-99.06M-288.74M-651.92M-88.19M-84.23M-48.61M76.50M
Financing Cash Flow-35.14M-58.24M-16.62M54.31M-16.25M-32.54M-68.60M-18.06M-28.02M-8.88M-9.19M-2.23M-15.83M14.74M-26.21M-15.16M-26.15M-29.39M-36.27M454.48M-48.65M-50.57M-81.30M-187.48M
Capital Expenditure15.93M6.58M10.43M5.37M6.35M8.98M7.54M10.90M12.59M14.08M13.98M7.20M5.32M4.67M6.78M8.14M11.80M23.94M41.29M39.72M36.23M34.94M30.68M35.30M
Free Cash Flow28.07M38.12M18.87M8.09M59.74M49.64M51.39M55.25M49.94M31.04M-11.57M20.71M42.88M94.45M112.02M91.29M80.90M74.87M167.05M130.14M92.04M125.63M117.86M102.67M
Dividends Paid5.81M5.34M4.99M4.82M5.17M5.18M5.00M9.68M10.41M10.77M13.53M16.49M16.65M16.86M20.12M20.32M23.46M24.84M26.24M27.61M35.60M37.02M38.32M38.03M
FCF to OCF63.80%85.28%64.40%60.11%90.39%84.68%87.20%83.53%79.87%68.79%-481.21%74.21%88.97%95.28%94.29%91.81%87.27%75.77%80.18%76.62%71.75%78.24%79.35%74.41%
Dividend Paid to FCF20.69%14.02%26.47%59.54%8.66%10.43%9.73%17.52%20.85%34.70%-116.93%79.61%38.84%17.85%17.96%22.25%29.00%33.17%15.71%21.22%38.68%29.47%32.51%37.04%

Earnings

Report DateDec 31, 2001Mar 31, 2003Jun 30, 2003Oct 21, 2003Mar 12, 2004May 4, 2004Aug 13, 2004Oct 26, 2004Mar 15, 2005Apr 27, 2005Aug 10, 2005Nov 3, 2005Mar 14, 2006Nov 1, 2006Mar 13, 2007Mar 11, 2014Aug 13, 2014Mar 18, 2015Aug 12, 2015Mar 15, 2016Aug 16, 2016Mar 15, 2017Aug 16, 2017Mar 14, 2018May 3, 2018Aug 16, 2018Oct 31, 2018Mar 11, 2019May 2, 2019Aug 15, 2019Oct 30, 2019Mar 17, 2020May 7, 2020Aug 12, 2020Nov 4, 2020Mar 16, 2021May 6, 2021Aug 18, 2021Nov 3, 2021Mar 15, 2022May 5, 2022Aug 17, 2022Nov 2, 2022Mar 14, 2023May 4, 2023Aug 15, 2023Nov 1, 2023Mar 12, 2024Jun 12, 2024Aug 8, 2024Nov 18, 2024Mar 12, 2025Aug 12, 2025Mar 16, 2026Mar 10, 2027
EPS Estimate---------0.310.210.090.66--0.000.000.000.000.000.000.002.240.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00-0.00-0.000.000.000.000.000.000.000.002.51--
EPS Actual0.610.280.54-0.090.470.490.300.280.360.290.120.440.680.741.250.000.000.000.002.732.002.662.193.440.002.460.003.500.002.130.003.990.003.010.005.670.006.850.003.200.005.330.004.180.000.000.000.000.000.000.003.541.41-10.15-
Surprise----------6.45%-42.86%388.89%3.03%----------2.23%------------------------------43.82%--
Timing----------Pre-marketPre-market---------------------------Pre-market-Pre-market-Pre-market-Pre-market--After-hours---After-hoursAfter-hoursPre-market

Key Statistics & Ratios

Market Cap3.11B
Enterprise Value2.67B
Trailing P/E0.00
Forward P/E25.64
PEG Ratio1.71
Price / Sales3.57
Price / Book2.40
EPS-9.65
Book Value90.71
Revenue (TTM)870.53M
Gross Profit (TTM)296.50M
EBITDA73.16M
Profit Margin-13.36%
Operating Margin4.16%
Return on Equity-9.69%
Return on Assets1.38%
Shares Outstanding12.32M
Shares Float12.27M
Beta1.01
Dividend Yield1.23%
Dividend Rate3.00
Payout Ratio60.61%

Dividends

20261×
1.50Apr 17, 2026
20251×
1.50Apr 14, 2025
20242×
0.36May 17, 20241.50Apr 22, 2024
20231×
1.45Apr 20, 2023
20221×
1.40Apr 14, 2022
20211×
1.15Apr 15, 2021
20201×
1.10Apr 9, 2020
20191×
2.10Apr 18, 2019
20181×
2.00Apr 19, 2018
20171×
1.75Apr 13, 2017
20161×
1.75Apr 15, 2016
20151×
1.50Apr 20, 2015
20141×
1.50Apr 16, 2014
20131×
0.50Apr 19, 2013
20121×
1.25Apr 20, 2012
20111×
1.00Apr 21, 2011
20101×
1.00Apr 23, 2010
20091×
0.90Apr 24, 2009
20082×
0.45Jul 18, 20080.45Apr 28, 2008
20072×
0.45Jul 12, 20070.45Apr 24, 2007
20061×
0.45May 2, 2006

Stock Splits

  • May 4, 200110:1
  • Jun 3, 199910:1